REYKJAVIK, Iceland, June 8, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture…
Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study in chronic inducible urticaria, to be highlighted in…
COPENHAGEN, Denmark, June 8, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on…
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) -- Astrall Dynamics demonstrated its Hypertron-T01 heavy-duty quadruped robot at INTERSCHUTZ 2026, demonstrating…
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) -- Astrall Dynamics at INTERSCHUTZ 2026’s debut demonstrated its Hypertron-T01 heavy-duty quadruped robot.…
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) -- Astrall Dynamics unveiled the Hypertron-T01 firefighting robot at INTERSCHUTZ 2026. The heavy-duty…
Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and…
MINNEAPOLIS, June 05, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company”), today announced…
MONTREAL, June 05, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health”, or the “Company”) announces…
•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility…